MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Prospect Venture Partners
Prospect Venture Partners:Portfolio
Satori Pharmaceuticals
Attachments
Aventor
Parents
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars)
Portfolio Companies: Puretech
Prospect Venture Partners:Portfolio
Venture Capital: Series B
Children
Cambridge, Massachusetts
Founded 2005
Satori Pharma raises $7 million (2011)
Satori’s early stage technology is designed to prevent certain proteins from being over-produced and becoming toxic to cells.
The company is first targeting Alzheimer’s with the goal of also developing drugs to combat other neurological diseases including Parkinson’s.
Venture investor firms include PureTech Ventures, Prospect Ventures, InterWest Partners, and New Enterprise Associates